1. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 3rd ed. Oxford, England: Clarendon Press, 1999.
  2. Halliwell B, Cross CE. Reactive oxygen species, antioxidants and acquired immunodeficiency syndrome. Arch Intern Med 1991; 157:29-31.
  3. Parks DA. Oxygen radicals: mediators of gastrointestinal pathophysiology. Gut 1989; 30:293-298.
  4. Southorn PA. Free radicals in medicine. II. Involvement in human disease. Mayo Clin Proc 1988; 63:390-408.
  5. Jones AF, Winkles JW, Jennings PE, et al. Serum antioxidant activity in diabetes mellitus. Diabetes Res 1988; 7:89-92.
  6. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Rad Biol Med 1994; 16:383-391.
  7. Halliwell B, Gutteridge JMC. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1984; 1:1396-1398.
  8. Halliwell B, Cross CE, Gutteridge JMC. Free radicals, antioxidants and human disease: where are we now? J Lab Clin Med 1992; 119:598-620.
  9. Sies H. ed. Oxidative Stress: Oxidants and Antioxidants. New York: Academic Press, 1991.
  10. Scorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, Sanderson MJ, Bodenham A. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996; 63:760765.
  11. Rosak C, Simon-Schnass I, Rösen P, Tritscher HJ, Halliwell B. Possible dietary induced a-tocopherol deficiency in type II diabetic patients. In preparation.
  12. Sinclair AJ, Lunec J. Free radicals, oxidative stress and diabetes mellitus. In: Winyard P, Blake DR, eds. Immunopharmacology of Free Radical Species. London: Academic Press, 1995:183-198.
  13. Maxwell SRJ, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GHG, Jones AF, Barnett AH. Antioxidant status in patients with uncomplicated insulin-

dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997; 27:484-490.

  1. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halli-well B, Betteridge DJ. Relationship between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 1997; 40:647-653.
  2. Kinnula VL, Crapo JD, Raivio KO. Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest 1995; 73:3-19.
  3. Kullik I, Stevens J, Teledano MB, Storz G. Mutational analysis of the redox-sensitive transcriptional regulator oxyR: regions important for DNA binding and multimerization. J Bacteriol 1995; 177:1285-1291.
  4. Hyslop PA, Hinshaw DB, Halsey WA Jr, et al. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem 1988; 263:1665-1675.
  5. Halliwell B. Antioxidant characterization: methodology and mechanisms. Bio-chem Pharmacol 1995; 49:1341-1348.
  6. Spencer JPE, Jenner A, Chimel K, Aruoma OI. Cross CE, Wu R, Halliwell B. DNA strand breakage and base modification induced by hydrogen peroxide treatment of human respiratory tract epithelial cells. FEBS Lett 1995; 374:233-236.
  7. Nicotera P, Orrenius S. Molecular mechanisms of toxic cell death: an overview. Methods Toxicol 1994; lB:23-28.
  8. Kohno T, Yamada Y, Hata T, Mori H, Yamamura M, Tomonaga M, Urata Y, Goto S, Kondo T. Relation of oxidative stress and glutathione synthesis to 095 (Fas/APO-1) mediated apoptosis of adult T cell leukemia cells. J Immunol 1996; 156:4722-4728.
  9. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sei USA 1996; 93:11848-11852.
  10. Hampton MB, Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apotosis. FEBS Lett 1997; 414:552-556.
  11. Mohr S, Zech B, Lapetina EG, Brune B. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem Biophys Res Commun 1997; 238: 387-391.
  12. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Rad Res 1996; 25:57-74.
  13. Wiseman H, Halliwell B. Carcinogenic antioxidants: diethylstilboestrol, hexoes-trol and 17a-ethynyl-oestradiol. FEBS Lett 1993; 322:159-163.
  14. Totter JR. Spontaneous cancer and its possible relationship to oxygen metabolism. Proc Natl Acad Sei USA 1980; 77:1763-1767.
  15. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sei USA 1993; 90:7915-7922.
  16. von Sonntag C. The Chemical Basis of Radiation Biology. London: Taylor and Francis, 1987.
  17. Steenken S. Purine bases, nucleosides and nucleotides: aqueous solution redox chemistry and transformation reactions of their radical cations and e" and OH' adducts. Chem Rev 1989; 89:503-520.
  18. Dizdaroglu M. Chemistry of free radical damage to DNA and nucleoproteins. In: Halliwell B, Aruoma Ol, eds. DNA and Free Radicals. Chichester: Ellis Hor-wood UK, 1993:19-39.
  19. Epe B. DNA damage induced by photosensitization. In: Halliwell B, Aruoma Ol, eds. DNA and Free Radicals. Chichester: Ellis Horwood UK, 1993:41-65.
  20. Cadet J, Ravanat JL, Buchko GW, et al. Singlet oxygen DNA damage: chromatographic and mass spectrometric analysis of damage products. Methods Enzymol 1994; 234:79-88.
  21. Spencer JPE, Wong J, Jenner A, Aruoma 01, Cross CE, Halliwell B. Base modification and strand breakage in isolated calf thymus DNA and in DNA from human skin epidermal keratinocytes exposed to peroxynitrite or 3-morpholino-sydnonimine. Chem Res Tox 1996; 9:1152-1158.
  22. Whiteman M, Jenner A, Halliwell B. Hypochlorous acid-induced base modification in isolated calf thymus DNA. Chem Res Tox 1997; 10:1240-1246.
  23. de Rojas-Walker T, Tamir S, Ji H, Wishnock JS, Tannenbaum SR. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem Res Toxicol 1995; 8:473-477.
  24. Yermilov V, Rubio J, Oshima H. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal by depurination. FEBS Lett 1995; 376:207-210.
  25. Floyd RA, Watson JJ, Wong PK, et al. Hydroxy-free radical adduct of deoxygua-nosine: sensitive detection and mechanisms of formation. Free Rad Res Commun 1986; 1:163-172.
  26. Stillwell WG, Xu HX, Adkins JA, et al. Analysis of methylated and oxidized purines in urine by capillary gas chromatography-mass spectrometry. Chem Res Toxicol 1989; 2:94-99.
  27. Halliwell B. Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition. Mutat Res 1999; 443:37-52.
  28. Ames BN. Endogenous oxidative DNA damage, aging, and cancer. Free Rad Res Commun 1989; 7:121-128.
  29. Loft S, Vistisen K, Ewertz M, et al. Oxidative DNA-damage estimated by 8-hydroxydeoxyguanosine excretion in man: influence of smoking, gender and body mass index. Carcinogenesis 1992; 13:2241-2247.
  30. Loft S, Fischer-Nielsen A, Jeding IB, et al. 8-Hydroxydeoxyguanosine as a urinary marker of oxidative DNA damage. J Toxicol Environ Health 1993; 40:391 -404.
  31. Teixeira AJR, Gommers-Ampt JH, van de Werken G, et al. Method for the analysis of oxidized nucleosides by gas chromatography/mass spectrometry. Anal Biochem 1993; 214:474-483.
  32. Sakumi K, Furuichi M, Tsuzuki T, et al. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis J Biol Chem 1993; 268:23524-23530.
  33. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347:444-445.
  34. Leinonen J, Lehtimäki T, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pasternack A, Alho H. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 1997; 417:150-152.
  35. Rehman A, Nourooz-Zadeh J, Möller W et al. Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus. FEBS Lett 1999; 448: 120-122.
  36. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320:915-924.
  37. Heinecke JW. Mechanisms of oxidative damage of low density lipoprotein in atherosclerosis. Curr Opin Lipidol 1997; 8:268-274.
  38. Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992; 13: 341-390.
  39. Pieper GM, Siebeneich W. Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J Cardiovasc Pharm 1997; 30:734-738.
  40. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nutr 1993; 57:715S-725S.
  41. Chirico S, Smith C, Marchant C, et al. Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Rad Res Commun 1993; 19:51-57.
  42. Akasaka K, Ohata A, Ohrui H, Meguro H. Automatic determination of hydroperoxides of phosphatidylcholine and phosphatidylethanolamine in human plasma. J Chromatogr 1995; B665:37-43.
  43. Frei B, Yamamoto Y, Niclas D, Ames BN. Evaluation of an isoluminol chemilu-minescence assay for the detection of hydroperoxides in human blood plasma. Anal Biochem 1988; 175:120-130.
  44. Holley AE, Slater TF. Measurement of lipid hydroperoxides in normal human blood plasma using HPLC-chemiluminescence linked to a diode array detector for measuring conjugated dienes. Free Rad Res Commun 1991; 15:51-63.
  45. Wilson R, Smith R, Wilson P, Shepherd MJ. Riemersma RA. Quantitative gas chromatography-mass spectrometry isomer-specific measurement of hydroxy fatty acids in biological samples and food as a marker of lipid peroxidation. Anal Biochem 1997; 248:76-85.
  46. Yasuda M, Narita S. Simultaneous determination of phospholipid hydroperoxides and cholesteryl ester hydroperoxides in human plasma by high-performance liquid chromatography with chemiluminescence detection. J Chromatogr 1997; 693:211-217.
  47. Moitow JD, Roberts LJ II. Mass spectrometry of prostanoids: F,-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol 1994; 233:163-174.
  48. Pratico D, Lawson JA, Fitzgerald GA. Cyclooxygenase-dependent formation of the isoprostane, 8-epiprostaglandin F2oc. J Biol Chem 1995; 270:9800-9808.
  49. Wang Z, Ciabattoni G, Creminon C, et al. Immunological characterization of urinary 8-epi-prostaglandin F2(1 excretion in man. J Pharmacol Exp Ther 1995; 275:94-100.
  50. Nourooz-Zadeh J, Gopaul NK, Barrow S, et al. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chro-matogr 1995; B667:199-208.
  51. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 1995; 332:1198-1203.
  52. Gopaul NK, Nourooz-Zadeh J, Mallet AI, Anggard EE. Formation of Frisopros-tanes during aortic endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett 1994; 348:297-300.
  53. Nourooz-Zadeh J, Liu EHC, Änggärd EE, Halliwell B. F4-isoprostanes: a novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA). Biochem Biophys Res Commun 1998; 242:338-344.
  54. Griesmacher A, KinderHauser M, Ändert S, et al. Enhanced serum levels of TBARS in diabetes mellitus. Am J Med 1995; 98:469-475.
  55. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanatthan M, Mohan R, Shanmu-gasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes with and without complications. Clin Sei 1996; 90:255-260.
  56. Velazques E, Winocour PH, Kesteven P. Alberti KGMM, Laker MF. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med 1991; 8:752-758.
  57. MacRury SM, Gordon D, Wilson R, et al. A comparison of different methods of assessing free radical activity in type 2 diabetes and peripheral vascular disease. Diabet Med 1993; 10:331-335.
  58. Gopaul NK, Anggard EE, Mallet AI, Betteridge DJ, Wolff SP, Nourooz-Zadeh J. Plasma 8-epi-PGF2„ levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 1995; 368:225-229.
  59. Burk RF, Ludden TM. Exhaled alkanes as indices of in vivo lipid peroxidation. Biochem Pharmacol 1989; 38:1029-1032.
  60. McGirr LG, Hadley M, Draper HH. Identification of Nrl-acetyl-e-(2-propenal) lysine as a urinary metabolite of malondialdehyde. J Biol Chem 1985; 260: 15427-15431.
  61. Dhanakoti SN, Draper HH. Response of urinary malondialdehyde to factors that stimulate lipid peroxidation in vivo. Lipids 1987; 22:643-646.
  62. Brown ED, Morris VC, Rhodes DG, et al. Urinary excretion of malondialdehyde in subjects fed meat cooked at high or low temperatures. Lipids 1995; 30:10531056.
  63. Gutteridge JMC, Tickner TR. The characterisation of thiobarbituric acid reactivity in human plasma and urine. Anal Biochem 1978; 91:250-257.
  64. Kosugi H, Kojima T, Kikugawa K. Characteristics of the thiobarbituric acid reactivity of human urine as a possible consequence of lipid peroxidation. Lipids 1993; 28:337-343.
  65. Kneepkens CMF, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Rad Biol Med 1994; 17:127160.
  66. Springfield JR, Levitt MD. Pitfalls in the use of breath pentane measurements to assess lipid peroxidation. J Lipid Res 1994; 35:1497-1504.
  67. Wade CR, van Rij AM. In vivo lipid peroxidation in Man as measured by the respiratory excretion of ethane, pentane and other low-molecular-weight hydrocarbons. Anal Biochem 1985; 150:1-7.
  68. Kohlmiiller D, Kochen W. Is /i-pentane really an index of lipid peroxidation in humans and animals? A methodological réévaluation. Anal Biochem 1993; 210: 268-276.
  69. Phillips M, Greenberg J, Sabas M. Alveolar gradient of pentane in normal human breath. Free Rad Res 1994; 20:333-337.
  70. Aruoma OI, Halliwell B, Butler J, Hoey BM. Apparent inactivation of arantipro-teinase by sulphur-containing radicals derived from penicillamine. Biochem Pharmacol 1989; 38:4353-4357.
  71. Becknian JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxy-nitrite. Methods Enzymol 1994; 233:229-240.
  72. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 1997; 411:157-160.
  73. Davies MJ, Dean RT. Radical-Mediated Protein Oxidation. From Chemistry to Medicine. Oxford, England: Oxford University Press, 1997.
  74. Wells-Knecht MC, Huggins TG, Dyer DG, et al. Oxidized amino acids in lens proteins with age. Measurement of «-tyrosine and dityrosine in the aging human lens. J Biol Chem. 1993; 268:12348-12352.
  75. Lubec G, Weninger M, Anderson SR. Racemization and oxidation studies of hair protein in the Homo tirolensis. FASEB J 1994; 8:1166-1169.
  76. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG. Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified protein. Methods Enzymol 1990; 186:464-487.
  77. Amici A, Levine RL, Tsai L, Stadtman ER. Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. J Biol Chem 1989; 264:3341-3346.
  78. Lyras L, Shaw PJ, Evans PJ, Halliwell B. Oxidative damage and motor neurone disease. Difficulties in the measurement of protein carbonyls in human brain tissue. Free Rad Res 1996; 24:397-406.
  79. Mayhan WG. Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain Res 1997; 760:204-209.
  80. Cosentino F, Hishikawa K, Katusic ZS, Lùscher TF. High glucose increases ni-

trie oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997; 96:25-28.

  1. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypsersele de Strihou C, Monnier VM, Witztum JL, Kurokawa K. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implications for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 1997; 100:2995-3004.
  2. Cominacini L, Young MMR, Capriati A, Garbin U, Fratta Pasini A, Campagnola M, Davoli, A, Rigoni A, Contessi GB, Lo Cascio V. Troglitazone increases the resistance of low density lipoprotein to oxidation in healthy volunteers. Diabeto-logia 1997; 40:1211-1218.
  3. Viana M, Herrera E, Bonet B. Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. Diabetologia 1996; 39:1041-1046.
  4. Hagay ZJ, Weiss Y, Zusman I, Peled-Kamar M, Reece EA, Eriksson UJ, Groner Y. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 1995; 173:1036-1041.

Was this article helpful?

0 0
Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment